Cargando…
Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate
Changes of cellular metabolism are an integral property of the malignant potential of most cancer cells. Already in the 1930s, Otto Warburg observed that tumor cells preferably utilize glycolysis and lactate fermentation for energy production, rather than the mitochondrial oxidative phosphorylation...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669744/ https://www.ncbi.nlm.nih.gov/pubmed/25569102 http://dx.doi.org/10.1038/cddis.2014.545 |
_version_ | 1782404156649111552 |
---|---|
author | Nilsson, H Lindgren, D Mandahl Forsberg, A Mulder, H Axelson, H Johansson, M E |
author_facet | Nilsson, H Lindgren, D Mandahl Forsberg, A Mulder, H Axelson, H Johansson, M E |
author_sort | Nilsson, H |
collection | PubMed |
description | Changes of cellular metabolism are an integral property of the malignant potential of most cancer cells. Already in the 1930s, Otto Warburg observed that tumor cells preferably utilize glycolysis and lactate fermentation for energy production, rather than the mitochondrial oxidative phosphorylation dominating in normal cells, a phenomenon today known as the Warburg effect. Even though many tumor types display a high degree of aerobic glycolysis, they still retain the activity of other energy-producing metabolic pathways. One exception seems to be the clear cell variant of renal cell carcinoma, ccRCC, where the activity of most other pathways than that of glycolysis has been shown to be reduced. This makes ccRCC a promising candidate for the use of glycolytic inhibitors in treatment of the disease. However, few studies have so far addressed this issue. In this report, we show a strikingly reduced mitochondrial respiratory capacity of primary human ccRCC cells, resulting in enhanced sensitivity to glycolytic inhibition by 3-Bromopyruvate (3BrPA). This effect was largely absent in established ccRCC cell lines, a finding that highlights the importance of using biologically relevant models in the search for new candidate cancer therapies. 3BrPA markedly reduced ATP production in primary ccRCC cells, followed by cell death. Our data suggest that glycolytic inhibitors such as 3BrPA, that has been shown to be well tolerated in vivo, should be further analyzed for the possible development of selective treatment strategies for patients with ccRCC. |
format | Online Article Text |
id | pubmed-4669744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-46697442015-12-08 Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate Nilsson, H Lindgren, D Mandahl Forsberg, A Mulder, H Axelson, H Johansson, M E Cell Death Dis Original Article Changes of cellular metabolism are an integral property of the malignant potential of most cancer cells. Already in the 1930s, Otto Warburg observed that tumor cells preferably utilize glycolysis and lactate fermentation for energy production, rather than the mitochondrial oxidative phosphorylation dominating in normal cells, a phenomenon today known as the Warburg effect. Even though many tumor types display a high degree of aerobic glycolysis, they still retain the activity of other energy-producing metabolic pathways. One exception seems to be the clear cell variant of renal cell carcinoma, ccRCC, where the activity of most other pathways than that of glycolysis has been shown to be reduced. This makes ccRCC a promising candidate for the use of glycolytic inhibitors in treatment of the disease. However, few studies have so far addressed this issue. In this report, we show a strikingly reduced mitochondrial respiratory capacity of primary human ccRCC cells, resulting in enhanced sensitivity to glycolytic inhibition by 3-Bromopyruvate (3BrPA). This effect was largely absent in established ccRCC cell lines, a finding that highlights the importance of using biologically relevant models in the search for new candidate cancer therapies. 3BrPA markedly reduced ATP production in primary ccRCC cells, followed by cell death. Our data suggest that glycolytic inhibitors such as 3BrPA, that has been shown to be well tolerated in vivo, should be further analyzed for the possible development of selective treatment strategies for patients with ccRCC. Nature Publishing Group 2015-01 2015-01-08 /pmc/articles/PMC4669744/ /pubmed/25569102 http://dx.doi.org/10.1038/cddis.2014.545 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International Licence. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons licence, users will need to obtain permission from the licence holder to reproduce the material. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0 |
spellingShingle | Original Article Nilsson, H Lindgren, D Mandahl Forsberg, A Mulder, H Axelson, H Johansson, M E Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate |
title | Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate |
title_full | Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate |
title_fullStr | Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate |
title_full_unstemmed | Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate |
title_short | Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate |
title_sort | primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-bromopyruvate |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669744/ https://www.ncbi.nlm.nih.gov/pubmed/25569102 http://dx.doi.org/10.1038/cddis.2014.545 |
work_keys_str_mv | AT nilssonh primaryclearcellrenalcarcinomacellsdisplayminimalmitochondrialrespiratorycapacityresultinginpronouncedsensitivitytoglycolyticinhibitionby3bromopyruvate AT lindgrend primaryclearcellrenalcarcinomacellsdisplayminimalmitochondrialrespiratorycapacityresultinginpronouncedsensitivitytoglycolyticinhibitionby3bromopyruvate AT mandahlforsberga primaryclearcellrenalcarcinomacellsdisplayminimalmitochondrialrespiratorycapacityresultinginpronouncedsensitivitytoglycolyticinhibitionby3bromopyruvate AT mulderh primaryclearcellrenalcarcinomacellsdisplayminimalmitochondrialrespiratorycapacityresultinginpronouncedsensitivitytoglycolyticinhibitionby3bromopyruvate AT axelsonh primaryclearcellrenalcarcinomacellsdisplayminimalmitochondrialrespiratorycapacityresultinginpronouncedsensitivitytoglycolyticinhibitionby3bromopyruvate AT johanssonme primaryclearcellrenalcarcinomacellsdisplayminimalmitochondrialrespiratorycapacityresultinginpronouncedsensitivitytoglycolyticinhibitionby3bromopyruvate |